Rocket制药

RCKT NASDAQ
15.43
+0.02
+0.13%
盘后: 15.43 0 0.00% 18:07 06/25 EDT
开盘
15.44
昨收
15.41
最高
16.07
最低
15.26
成交量
19.01万
成交均量(3M)
30.66万
52周最高
25.96
52周最低
10.75
换手率
0.38%
市值
7.76亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Rocket制药 RCKT股票价格,Rocket制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapy treatment options for rare, devastating diseases. The Company’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The Company’s lead clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a genetic disease that leads to bone marrow failure and potentially cancer. Its additional pipeline programs for bone marrow-derived disorders are for Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-I (LAD-I) and Infantile Malignant Osteopetrosis (IMO). The Company is also developing an AAV-based gene therapy program for pediatric heart failure indication, Danon disease.
展开 >

最近浏览

名称
价格
涨跌幅